FDA Inspection
Southern Tissue CenterSouthern Tissue Center – FDA Inspection, Jun 3, 2016
Record Details
This FDA Inspection record concerns Southern Tissue Center, with an inspection on June 3, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Southern Tissue Center
- Inspection Date
- June 3, 2016
- Product Type
- Biologics
View Company Profile
ID · ed7525f7-4a34-43b4-8aca-3cebcdd3bf69
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 980031
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
4- 21 CFR 1271.195(a)Adequate control, proper conditions
- 21 CFR 1271.250(c)All labeling requirements met
- 21 CFR 1271.230(a)Process validation procedures
- 21 CFR 1271.230(b)Reduced risk representation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Southern Tissue Center
1| Date | Classification | Office | Project area |
|---|---|---|---|
| December 12, 2012 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Southern Tissue Center
- FDA Inspection 812540 - 2012-12-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.